PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 2 days 6 hours 13 minutes
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
PARP Inhibitors for Ovarian Cancer: Making the Right Choices at the Right Times
Getting at the Heart of Comprehensive Disease Control in Type 2 Diabetes: What’s New?
Visit https://www.peervoice.com/QZR860 to view the entire programme with slides.
Novel Options for Relief for Women Suffering From Endometriosis-Related Pain: Evolving Perspectives for Canadian Clinicians
Visit https://www.peervoice.com/PAX860 to view the entire programme with slides.
A Closer Look at Safety of Glucose-Lowering Therapy
A Closer Look at Safety of Glucose-Lowering Therapy
Developing a Patient–Clinician Partnership in RA: Optimising Shared Decision-Making to Improve Patient Outcomes
Visit https://www.peervoice.com/PXE860 to view the entire programme with slides.
Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety
Improving Outcomes in Type 2 Diabetes: Focus on Cardiovascular and Renal Safety
Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
Ticking All the Boxes: A Multidisciplinary Approach to Hidradenitis Suppurativa
Considering the Possibility of Psoriatic Arthritis in Patients With Psoriasis
Considering the Possibility of Psoriatic Arthritis in Patients With Psoriasis
Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know
Cardiovascular and Renal Safety in Type 2 Diabetes: What Clinicians Need to Know